Clinical relevance of proteinase activated receptors (pars) in the gut.
Vergnolle
N
N
Mucosal Inflammation Research Group, Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, 3330 Hospital Drive NW Calgary, Alberta, Canada T2N4N1. nvergnol@ucalgary.ca
D049109:Cell Proliferation; D003092:Colitis / Q000378:metabolism / Q000473:pathology; D003110:Colonic Neoplasms / Q000378:metabolism / Q000473:pathology; D005756:Gastritis / Q000209:etiology; D005769:Gastrointestinal Motility / Q000502:physiology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000378:metabolism / Q000473:pathology; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000473:pathology; D017136:Ion Transport / Q000502:physiology; D043183:Irritable Bowel Syndrome / Q000378:metabolism / Q000473:pathology; D009119:Muscle Contraction; D009475:Neurons, Afferent / Q000502:physiology; D010539:Permeability; D044462:Receptors, Proteinase-Activated / Q000378:metabolism*
D044462:Receptors, Proteinase-Activated